7th Jun 2007 11:00
Intertek Group plc (Intertek), a leading international provider ofquality and safety services to a wide range of industries, hasacquired Quantitative Technologies Inc. (QTI). QTI will operate in theIntertek OCA Division (Caleb Brett) Pharmaceutical Services group. £ QTI is a leading contract analytical research and developmentlaboratory that has been serving the pharmaceutical, medical deviceand drug delivery industry in North America for over 15 years,specialising in the pre-market launch stages of the drug and productdevelopment life cycle. QTI is located in Whitehouse, New Jersey withapproximately 60 staff and counts major global pharmaceuticalcompanies among its clients. The laboratory is highly regarded fortechnical expertise, rigorous compliance programs, and outstandingcustomer service - it is a current Good Manufacturing Practice (cGMP)facility in good standing with the US Food and Drug Administration(FDA). £ The acquisition further advances Intertek's strategic growth inexpert support services to the global pharmaceutical, medical deviceand drug delivery industry through the provision of state of the artanalytical services. £ CEO of Intertek's OCA Division (Caleb Brett), Mark Loughead,comments: "QTI has an outstanding reputation in the industry and willfurther expand our ability to support the pharmaceutical and relatedsectors for outsourced R&D and testing expertise." £ John Conti-Ramsden, Ph.D., global director for IntertekPharmaceutical Services, said: "The acquisition of QTI furtherdevelops Intertek's USA offering and global platform in the area ofpharmaceutical services. Intertek already provides a wide range oftesting services to pharmaceutical clients from its laboratories inEurope and Good Laboratory Practice (GLP) bio-analytical services fromthe Alta laboratories in California." £ Paul Winslow, Ph.D., managing director of QTI comments: "JoiningIntertek provides QTI a global network to access and serve theworldwide pharmaceutical industry. Additionally, Intertek's commitmentto growth will allow QTI to expand our capabilities to provide a morecomprehensive service offering to our key industry markets." £ About Intertek: £ Intertek Group plc (LSE:ITRK) is a leading international providerof quality and safety services to a wide range of global and localindustries. Partnership with Intertek brings increased value tocustomers' products and processes, ultimately supporting their successin the global market place. Intertek has the experience, expertise,resources and global reach to support its customers through theirnetwork of 930 laboratories and offices, 18,000 people in 109countries around the world. www.intertek.com £ About Intertek Pharmaceutical Services: £ Intertek's Pharmaceutical and Speciality Chemical Laboratoriesprovide a wide range of routine and non-routine laboratory testingservices to support pharmaceutical, biotechnology and nanotechnologyclients. A growing international network of Intertek laboratories andoffices serve clients from a wide range of industries on a globalbasis with services including laboratory testing, outsourcing,inspection, R&D and process services. Intertek laboratories areideally suited to support a diverse range of fine chemical,pharmaceutical and biotech activities. £ www.intertek-cb.com/pharma £ About QTI: £ QTI is a FDA and DEA registered contract Analytical Research &Development Laboratory, operating in accordance with cGMP regulationsand associated guidance documents. Located in Whitehouse, NJ, QTI hasbeen providing complete analytical solutions to the pharmaceutical andbiotechnology communities since 1989. QTI's mission is to exceedclients' expectations by providing innovative solutions for theiranalytical challenges and to help them achieve their technicalbusiness objectives while maintaining the highest level of qualityassurance and regulatory compliance. Copyright Business Wire 2007Related Shares:
Intertek Group